Skip to content

Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft

Clinical and Radiographic Outcomes of the Apical Approach in Periodontal Surgery Reconstruction With and Without Graft Materials: Non-Incised Papillae Surgical Approach (NIPSA). A Randomized Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04712630
Acronym
NIPSAGRAFT
Enrollment
24
Registered
2021-01-15
Start date
2019-09-09
Completion date
2020-12-30
Last updated
2021-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Attachment Loss, Periodontal Diseases, Periodontal Pocket, Periodontitis

Brief summary

This study compared the clinical outcomes of the non-incised papila surgical approach (NIPSA) alone and with grafting biomaterial.

Interventions

PROCEDURENon-incised papila surgical approach without grafting biomaterial

Periodontal reconstructive surgery

PROCEDURENon-incised papila surgical approach with grafting biomaterial

Periodontal reconstructive surgery

Sponsors

Universidad de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients diagnosed with periodontitis. * plaque index and bleeding index of \< 30%. * periodontal lesions with pocket probing depth \> 5 mm. * intrabony defect \> 3 mm. * intrabony defect configuration including a 1 and/or 2-wall component, always involving the buccal wall.

Exclusion criteria

* patients with systemic diseases that contraindicated treatment. * third molars. * teeth with incorrect endodontic or restorative treatment.

Design outcomes

Primary

MeasureTime frameDescription
Probing pocket depth (PD)12 monthsProbing pocket depth will be assessed with a periodontal probe, measured in mm from the gingival margin to the bottom of the pocket
Clinical attachment level (CAL)12 monthsClinical attachment level will be assessed with a periodontal probe, measured in mm from the cementoenamel junction (CEJ) to the bottom of the pocket.
Recession (REC)12 monthsRecession, will be assessed with a periodontal probe, measured in mmm on the buccal aspect, from the CEJ to the gingival margin zenith.
Location of the tip of the papillae (TP)12 monthsLocation of the tip of the papillae. Taking as reference the level of the mid-axis of the tooth, will be measured the distance from the CEJ at the zenith of the tooth to the tip of the papilla. A positive value will be recorded when the tip of the papillae is located coronally to the CEJ and a negative value otherwise. This outcome will be assessed with a periodontal probe and measured in mm.
Keratinized tissue width (KT)12 monthsKeratinized tissue width will be assessed with a periodontal probe, measured in mm on the buccal aspect, from the gingival margin to the mucogingival line.
Bleeding on probing12 monthsBleeding on probing could be positive or negative.

Secondary

MeasureTime frameDescription
Supra-alveolar attachment gain (SUPRA-AG)12 monthsSubtracting the 12-month CAL from the intra-surgically BC-CEJ will provide the SUPRA-AG result.
Wound closure (WC)1 weekComplete wound closure (CWC = 2) Incomplete wound closure (IWC = 1) necrosis (NT = 0).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026